Are High Doses of Prednisone Necessary for Treatment of Interstitial Lung Disease in Systemic Sclerosis?

Autor:	PérezCampos, Dionisio, DelToro, Miguel Estévez, Pena Casanovas, Aisa, González Rojas, Pedro Pablo, Morales Sánchez, Lisvenia, Gutiérrez Rojas, Ángela Rosa
Předmět:	LUNG disease treatment SYSTEMIC scleroderma MORTALITY CYCLOPHOSPHAMIDE PREDNISONE CLINICAL trials DRUG dosage
Zdroj:	Reumatología Clínica; mar/abr2012, Vol. 8 Issue 2, p58-62, 5p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu